TP53 and cancer: According to reports, the plasma concentration of proline in the model group was significantly reduced compared with the control group, and the rapid increase of proline dehydrogenase transcription by the tumor suppressor p53 triggered the degradation of this amino acid in cancer (Zhao et al., 2014; Phang et al., 2015).